We target the future of proteomics for biomarker discovery and cell signaling research

Biognosys is a biotechnology company with a next generation targeted proteomics platform for sensitive and accurate protein quantification. Biognosys’ technology can be applied as a versatile and robust technique to measure expression levels of virtually any protein from tissue samples or cell cultures.

With our patent protected assay design platform we aim to be the first company to map out the human proteome with quantitative assays for biomarker discovery and applications in biotechnology. We believe that targeted proteomics will fundamentally transform the way we do biology in the future and Biognosys is at the forefront of this development.

"Revolutions in science have often been preceded by revolutions in measurement" (Sinan Aral, NYU)